HCW Biologics executes 1-for-6 reverse stock split

HCW Biologics, Inc.

HCW Biologics, Inc.

HCWB

0.00
  • HCW Biologics to execute a 1-for-6 reverse stock split on June 30, 2026 to support Nasdaq bid-price compliance.
  • Nasdaq hearings panel found on June 29, 2026 that the company regained compliance with Listing Rule 5550(a)(2).
  • Shares remain subject to a mandatory Nasdaq monitoring period through June 17, 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCW Biologics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606300825PRIMZONEFULLFEED9754555) on June 30, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.